-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
BioNexus Gene Lab Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q3 2024.
- BioNexus Gene Lab Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $1.56K, a 98% decline year-over-year.
- BioNexus Gene Lab Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$172K, a 13173% decline year-over-year.
- BioNexus Gene Lab Corp annual Income Tax Expense (Benefit) for 2023 was -$21.5K, a 58.8% increase from 2022.
- BioNexus Gene Lab Corp annual Income Tax Expense (Benefit) for 2022 was -$52.3K, a 82% increase from 2021.
- BioNexus Gene Lab Corp annual Income Tax Expense (Benefit) for 2021 was -$291K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)